Approval · Notice of Compliance 13437 · 2012
PMS-TIMOLOL: Notice of Compliance 13437
Issued June 27, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13437
- Date
- June 27, 2012
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- ALternate formulation, manufacturing procedure and manufacturing site
- Therapeutic class
- Elevated Intraocular Pressure Therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-TIMOLOL | 02083353 | Cancelled Post Market |
| PMS-TIMOLOL | 02083345 | Cancelled Post Market |
Medicinal ingredients
- TIMOLOL MALEATE 0.25 PER
- TIMOLOL MALEATE 0.5 PER